Endolymphatic hydrops is a condition where excess fluid builds up inside the inner ear, distorting the delicate membranes that control hearing and balance. The inner ear contains two types of fluid, endolymph and perilymph, separated by thin membranes. When endolymph accumulates faster than the body can absorb it, pressure rises and those membranes balloon outward, interfering with the signals your brain relies on to hear sounds and maintain equilibrium.
How Fluid Balance Breaks Down
Your inner ear has a small structure called the endolymphatic sac that works much like the kidney. Its lining absorbs sodium and regulates the volume of endolymph circulating through the cochlea (the hearing organ) and the vestibular system (the balance organ). When the endolymphatic sac is damaged, blocked, or dysfunctional, it can no longer drain fluid efficiently. Animal studies show that removing the endolymphatic sac produces mild fluid buildup within days, progressing to severe membrane distension over the following months.
Two main mechanisms drive the problem. First, changes in pressure between the endolymph and perilymph compartments can force the endolymphatic space to expand, sometimes described as a “vacuum phenomenon” where falling perilymph pressure leaves room for the endolymph side to swell. Second, abnormal protein concentrations in the inner ear can draw extra fluid into the endolymphatic space through osmotic pressure, much like salt draws water. In some cases, protein-rich fluid from the enlarged endolymphatic sac flows backward into the cochlea, damaging the hair cells responsible for detecting sound.
The condition can be idiopathic, meaning no clear cause is found, or secondary to another problem. Secondary causes include structural abnormalities like a dehiscence (tiny hole) in the bone of a semicircular canal, tumors near the endolymphatic sac, changes in intracranial pressure, and inner ear infections or trauma.
The Link to Ménière’s Disease
Endolymphatic hydrops and Ménière’s disease are closely related but not identical. Ménière’s disease is the clinical syndrome, defined by its symptoms: episodic vertigo, fluctuating hearing loss, tinnitus, and a feeling of fullness or pressure in the ear. Endolymphatic hydrops is the underlying physical change in the inner ear that drives those symptoms. Not everyone with detectable hydrops on imaging develops full Ménière’s disease, and the severity of fluid buildup doesn’t always predict how bad the symptoms will be.
Ménière’s disease affects roughly 190 per 100,000 people in the United States, though estimates vary widely, from as low as 3.5 per 100,000 to as high as 513 per 100,000 in Finland. Prevalence rises sharply with age: about 9 per 100,000 in people under 18, climbing to 440 per 100,000 in those 65 and older. It occurs more often in women and in white populations.
What the Symptoms Feel Like
The hallmark symptom is episodic vertigo, a sensation that the room is spinning around you. In the early stages of the disease, these episodes typically last between 20 minutes and 4 hours. As the condition progresses over years, attacks often become shorter, sometimes lasting only about a minute, but may shift in character.
Hearing loss tends to affect lower-pitched sounds first. It fluctuates early on, meaning your hearing may return to near-normal between episodes, but over time the loss becomes more permanent. Initially the hearing loss is almost always in one ear, but bilateral involvement becomes increasingly common: about 14% of people develop hearing loss in both ears within the first year, rising to roughly 35% after a decade. Tinnitus, often described as a roaring or buzzing sound, and a feeling of pressure or fullness in the affected ear typically accompany the vertigo and hearing changes.
How It’s Diagnosed
Diagnosis relies primarily on the pattern of symptoms. The current criteria distinguish between definite and probable Ménière’s disease. A definite diagnosis requires episodic vertigo lasting 20 minutes to 12 hours, documented low- to mid-frequency hearing loss on a hearing test, and fluctuating ear symptoms (hearing changes, tinnitus, or fullness) in the affected ear. Probable Ménière’s disease is a broader category that includes episodic dizziness or vertigo with fluctuating ear symptoms, with episodes lasting 20 minutes to 24 hours.
Two types of testing can provide additional evidence. Electrocochleography measures the electrical response of the inner ear to sound, looking at the ratio between two specific signals. An abnormally high ratio suggests increased fluid pressure in the cochlea. The test has a positive predictive value of roughly 67% to 83% depending on the measurement method, so a normal result doesn’t rule out hydrops.
MRI imaging has become the most direct way to visualize hydrops. A contrast agent is injected into a vein, and images are taken about 4 hours later. The contrast seeps into the perilymph but not the endolymph, creating a visual map of both fluid compartments. Radiologists grade the hydrops on a scale from none to grade II. Grade I shows mild swelling of the endolymph space with perilymph still visible around it. Grade II means the endolymph has expanded to fill the entire bony space, completely displacing the perilymph.
Dietary and Lifestyle Changes
Reducing sodium intake is one of the first recommendations for managing hydrops symptoms. The standard target is under 2,000 mg of sodium per day. The reasoning is that lower sodium intake triggers hormonal changes, specifically an increase in aldosterone, that help the endolymphatic sac absorb more endolymph, reducing pressure. While the theory is sound, the direct evidence that this works remains limited. Many people do report fewer or milder episodes after committing to a low-sodium diet, and because the intervention carries no real risk, it remains a standard starting point.
Caffeine and alcohol are also commonly flagged as potential triggers, though individual sensitivity varies. Staying well hydrated and maintaining consistent meal timing can help avoid the kind of fluid shifts that may provoke episodes.
Medications
The two most common medication approaches are betahistine and diuretics. Betahistine is thought to work by improving blood flow to the inner ear’s fluid-producing tissue or by calming activity in the brain’s balance centers. It is widely prescribed in Europe and parts of Asia, though a Cochrane review found insufficient evidence to confirm it is effective. Many patients report subjective improvement, which keeps it in clinical use despite the uncertain evidence base.
Diuretics, particularly thiazide types, are prescribed to reduce overall fluid volume in the body, with the goal of lowering endolymph pressure. Other types include potassium-sparing diuretics, loop diuretics, and carbonic anhydrase inhibitors. Like betahistine, diuretics are commonly used but lack strong clinical trial evidence supporting their effectiveness specifically for hydrops.
Injections Through the Eardrum
When medications and dietary changes aren’t enough, doctors can deliver treatment directly into the middle ear through the eardrum. Two main agents are used, and they serve very different purposes.
Steroid injections aim to reduce inflammation and swelling in the inner ear without damaging any structures. They’re typically tried first in people whose symptoms aren’t controlled by oral medications. The procedure is done in a clinic setting: a small needle passes through the eardrum, and the medication pools against the round window membrane, where it can diffuse into the inner ear.
Gentamicin injections take a more aggressive approach. This antibiotic is selectively toxic to the balance-sensing cells of the inner ear, essentially performing a chemical shutdown of the vestibular system on the affected side. It provides superior vertigo control compared to steroids, with a meta-analysis showing complete vertigo control in about 74% of patients overall and up to 82% with a specific dosing approach. The trade-off is a risk of further hearing loss, since the drug can also damage hearing cells. For this reason, gentamicin is generally reserved for people with severe, disabling vertigo who haven’t responded to less destructive treatments.
Surgical Options
Surgery is considered when all other approaches have failed. The most common procedure is endolymphatic sac decompression, where the surgeon removes bone around the endolymphatic sac to give it more room and improve fluid drainage. Some variations place a small shunt to help fluid exit the sac. The average success rate for vertigo control is around 80%, with long-term studies showing 75% to 82% of patients maintaining vertigo control after roughly three years. One long-term study following patients for an average of nine years found vertigo control in 94% of those with unilateral disease, though a separate 10-year study reported a lower figure of about 65%.
For people with severe, uncontrollable symptoms in one ear, more definitive surgeries exist. Vestibular nerve section cuts the balance nerve while preserving hearing. Labyrinthectomy removes the entire balance organ, permanently eliminating vertigo from that ear but also destroying any remaining hearing on that side. These are last-resort procedures, chosen when the affected ear has already lost most of its useful hearing or when vertigo is so debilitating that the certainty of relief outweighs the cost.
How the Condition Changes Over Time
Endolymphatic hydrops is not static. In the early years, the pattern tends to be dramatic episodes of spinning vertigo separated by relatively normal periods. Over time, the acute spinning episodes often become less intense or less frequent, but a more persistent sense of imbalance or unsteadiness can develop. Hearing loss, which initially comes and goes, gradually becomes permanent as repeated fluid distension damages the delicate hair cells in the cochlea.
The progression to bilateral involvement is a real concern. While most people start with symptoms in one ear, roughly one in four will have both ears affected within four years. This makes long-term monitoring of the unaffected ear important, even during periods when symptoms feel well controlled.